A Highly Sensitive Pan-Cancer Test for Microsatellite Instability.
暂无分享,去创建一个
J. Eshleman | S. Gallinger | D. Buchanan | E. Udho | R. Halberg | D. Storts | I. Vyazunova | R. Pai | J. Bacher | E. Strauss | Allyson S. Templeton
[1] Christina B. Ventura,et al. Mismatch Repair and Microsatellite Instability Testing for Immune Checkpoint Inhibitor Therapy. , 2022, Archives of pathology & laboratory medicine.
[2] J. Reis-Filho,et al. Microsatellite instability-high endometrial cancers with MLH1 promoter hypermethylation have distinct molecular and clinical profiles. , 2022, Clinical cancer research : an official journal of the American Association for Cancer Research.
[3] L. Kauppi,et al. Single-Cell Mononucleotide Microsatellite Analysis Reveals Differential Insertion-Deletion Dynamics in Mouse T Cells , 2022, Frontiers in Genetics.
[4] F. Sessa,et al. Critical aspects of MSI testing in endometrial cancer: a comparison study. , 2022, Human pathology.
[5] E. Vakiani,et al. Detecting mismatch repair deficiency in solid neoplasms: immunohistochemistry, microsatellite instability, or both? , 2022, Modern Pathology.
[6] M. Caraglia,et al. Microsatellite Status Detection in Gastrointestinal Cancers: PCR/NGS Is Mandatory in Negative/Patchy MMR Immunohistochemistry , 2022, Cancers.
[7] P. Jares,et al. Comparison of the Idylla™ MSI assay with the Promega™ MSI Analysis System and immunohistochemistry on formalin-fixed paraffin-embedded tissue of endometrial carcinoma: results from an international, multicenter study , 2022, Virchows Archiv.
[8] A. Uguen,et al. Idylla MSI test combined with immunohistochemistry is a valuable and cost effective strategy to search for microsatellite instable tumors of noncolorectal origin , 2022, Pathology international.
[9] J. Eshleman,et al. Validation of long mononucleotide repeat markers for detection of microsatellite instability. , 2021, The Journal of molecular diagnostics : JMD.
[10] M. Dwyer,et al. NCCN Guidelines® Insights: Genetic/Familial High-Risk Assessment: Colorectal, Version 1.2021. , 2021, Journal of the National Comprehensive Cancer Network : JNCCN.
[11] M. Mansukhani,et al. Investigation of Discrepant MMR IHC and MSI PCR Test Results for Gynecologic Cancers using Next Generation Sequencing. , 2021, Human pathology.
[12] L. Kauppi,et al. Tissue-specific reduction in MLH1 expression induces microsatellite instability in intestine of Mlh1+/- mice. , 2021, DNA repair.
[13] I. Bernstein,et al. An Update on Immune Checkpoint Therapy for the Treatment of Lynch Syndrome , 2021, Clinical and experimental gastroenterology.
[14] A. Duval,et al. Discordance between immunochemistry of mismatch repair proteins and molecular testing of microsatellite instability in colorectal cancer , 2021, ESMO open.
[15] L. Fashoyin-Aje,et al. FDA Approval Summary: Pembrolizumab for the First-line Treatment of Patients with MSI-H/dMMR Advanced Unresectable or Metastatic Colorectal Carcinoma , 2021, Clinical Cancer Research.
[16] J. Hechtman,et al. Reply to Singh et al. , 2021, Modern Pathology.
[17] M. Jackson,et al. How Should We Test for Lynch Syndrome? A Review of Current Guidelines and Future Strategies , 2021, Cancers.
[18] E. Oki,et al. Real‐world data on microsatellite instability status in various unresectable or metastatic solid tumors , 2021, Cancer science.
[19] G. Getz,et al. DNA polymerase and mismatch repair exert distinct microsatellite instability signatures in normal and malignant human cells. , 2020, Cancer discovery.
[20] E. Sokol,et al. Predictive Biomarkers for Immune Checkpoint Inhibitors in Metastatic Breast Cancer , 2020, Cancer medicine.
[21] I. Nagtegaal,et al. Somatic non-epigenetic mismatch repair gene aberrations underly most mismatch repair-deficient Lynch-like tumors. , 2020, Gastroenterology.
[22] J. Eshleman,et al. Tumor Frameshift Mutation Proportion Predicts Response to Immunotherapy in Mismatch Repair‐Deficient Prostate Cancer , 2020, The oncologist.
[23] M. Khasraw,et al. Tumor Mutational Burden as a Predictor of Immunotherapy Response: Is More Always Better? , 2020, Clinical Cancer Research.
[24] B. Clarke,et al. Interpretation of mismatch repair protein expression using obsolete criteria results in discrepancies with microsatellite instability and mutational testing results. Comment on Hechtman et al. Mod Pathol 2020; 33:871–879 , 2020, Modern Pathology.
[25] Ronald J. Hause,et al. Identifying Optimal Loci for the Molecular Diagnosis of Microsatellite Instability. , 2020, Clinical chemistry.
[26] M. Kloor,et al. The shared frameshift mutation landscape of microsatellite-unstable cancers suggests immunoediting during tumor evolution , 2020, Nature Communications.
[27] M. Salto‐Tellez,et al. Identifying mismatch repair‐deficient colon cancer: near‐perfect concordance between immunohistochemistry and microsatellite instability testing in a large, population‐based series , 2020, Histopathology.
[28] M. Arends,et al. Molecular pathology of Lynch syndrome , 2020, The Journal of pathology.
[29] L. Diaz,et al. Efficacy of Pembrolizumab in Patients With Noncolorectal High Microsatellite Instability/Mismatch Repair-Deficient Cancer: Results From the Phase II KEYNOTE-158 Study. , 2020, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[30] Ahmet Zehir,et al. Retained Mismatch Repair Protein Expression Occurs in Approximately 6% of Microsatellite Instability-High Cancers and is Associated with Missense Mutations in Mismatch Repair Genes. , 2019, Modern Pathology.
[31] Aung Ko Win,et al. Cancer risks by gene, age, and gender in 6350 carriers of pathogenic mismatch repair variants: findings from the Prospective Lynch Syndrome Database , 2019, Genetics in Medicine.
[32] Ahmet Zehir,et al. Genetic diversity of tumors with mismatch repair deficiency influences anti–PD-1 immunotherapy response , 2019, Science.
[33] Y. Xi,et al. Screening of MSI detection loci and their heterogeneity in East Asian colorectal cancer patients , 2019, Cancer medicine.
[34] Ahmet Zehir,et al. Microsatellite Instability Is Associated With the Presence of Lynch Syndrome Pan-Cancer. , 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[35] Serena Wong,et al. Minimal microsatellite shift in microsatellite instability high endometrial cancer: a significant pitfall in diagnostic interpretation , 2018, Modern Pathology.
[36] H. Lenz,et al. Microsatellite instability in colorectal cancer: overview of its clinical significance and novel perspectives. , 2018, Clinical advances in hematology & oncology : H&O.
[37] T. Yamanaka,et al. Utility of the quasi‐monomorphic variation range in unresectable metastatic colorectal cancer patients , 2018, Cancer science.
[38] Aung Ko Win,et al. Cohort Profile: The Colon Cancer Family Registry Cohort (CCFRC). , 2018, International journal of epidemiology.
[39] J. Marshall,et al. Microsatellite instability status determined by next‐generation sequencing and compared with PD‐L1 and tumor mutational burden in 11,348 patients , 2018, Cancer medicine.
[40] Ahmet Zehir,et al. Reliable Pan-Cancer Microsatellite Instability Assessment by Using Targeted Next-Generation Sequencing Data. , 2017, JCO precision oncology.
[41] Russell Bonneville,et al. Landscape of Microsatellite Instability Across 39 Cancer Types. , 2017, JCO precision oncology.
[42] Ludmila V. Danilova,et al. Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade , 2017, Science.
[43] Levi Garraway,et al. Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden , 2017, Genome Medicine.
[44] P. Devilee,et al. Comprehensive Mutation Analysis of PMS2 in a Large Cohort of Probands Suspected of Lynch Syndrome or Constitutional Mismatch Repair Deficiency Syndrome , 2016, Human mutation.
[45] P. Park,et al. A molecular portrait of microsatellite instability across multiple cancers , 2016, Nature Communications.
[46] Jay Shendure,et al. Classification and characterization of microsatellite instability across 18 cancer types , 2016, Nature Medicine.
[47] Aung Ko Win,et al. Germline mutations in PMS2 and MLH1 in individuals with solitary loss of PMS2 expression in colorectal carcinomas from the Colon Cancer Family Registry Cohort , 2016, BMJ Open.
[48] L. Clipson,et al. Improved Detection of Microsatellite Instability in Early Colorectal Lesions , 2015, PloS one.
[49] W. Frankel,et al. Colon and endometrial cancers with mismatch repair deficiency can arise from somatic, rather than germline, mutations. , 2014, Gastroenterology.
[50] Colin C Pritchard,et al. Microsatellite instability detection by next generation sequencing. , 2014, Clinical chemistry.
[51] I. Nagtegaal,et al. Somatic mutations in MLH1 and MSH2 are a frequent cause of mismatch-repair deficiency in Lynch syndrome-like tumors. , 2014, Gastroenterology.
[52] K. Halling,et al. Summary of microsatellite instability test results from laboratories participating in proficiency surveys: proficiency survey results from 2005 to 2012. , 2014, Archives of pathology & laboratory medicine.
[53] Peter J. Park,et al. The Landscape of Microsatellite Instability in Colorectal and Endometrial Cancer Genomes , 2013, Cell.
[54] G. I. Lang,et al. Mutation Rates, Spectra, and Genome-Wide Distribution of Spontaneous Mutations in Mismatch Repair Deficient Yeast , 2013, G3: Genes, Genomes, Genetics.
[55] M. Bronner,et al. A Five-marker Panel in a Multiplex PCR Accurately Detects Microsatellite Instability-high Colorectal Tumors Without Control DNA , 2012, Diagnostic molecular pathology : the American journal of surgical pathology, part B.
[56] A. N. Bartley,et al. Identification of Cancer Patients with Lynch Syndrome: Clinically Significant Discordances and Problems in Tissue-Based Mismatch Repair Testing , 2011, Cancer Prevention Research.
[57] Juliane C. Dohm,et al. Evaluation of genomic high-throughput sequencing data generated on Illumina HiSeq and Genome Analyzer systems , 2011, Genome Biology.
[58] J. Hopper,et al. Quality assessment and correlation of microsatellite instability and immunohistochemical markers among population- and clinic-based colorectal tumors results from the Colon Cancer Family Registry. , 2011, The Journal of molecular diagnostics : JMD.
[59] R. Yantiss,et al. Neoadjuvant Therapy Induces Loss of MSH6 Expression in Colorectal Carcinoma , 2010, The American journal of surgical pathology.
[60] A. Wagner,et al. Tumours with loss of MSH6 expression are MSI-H when screened with a pentaplex of five mononucleotide repeats , 2010, British Journal of Cancer.
[61] F. Hogervorst,et al. A novel pathogenic MLH1 missense mutation, c.112A > C, p.Asn38His, in six families with Lynch syndrome , 2010, Hereditary cancer in clinical practice.
[62] Kateryna D. Makova,et al. What Is a Microsatellite: A Computational and Experimental Definition Based upon Repeat Mutational Behavior at A/T and GT/AC Repeats , 2010, Genome biology and evolution.
[63] E. Kuipers,et al. A review on the molecular diagnostics of Lynch syndrome: a central role for the pathology laboratory , 2009, Journal of cellular and molecular medicine.
[64] H. Hollema,et al. Mononucleotide precedes dinucleotide repeat instability during colorectal tumour development in Lynch syndrome patients , 2009, The Journal of pathology.
[65] H. Lynch,et al. Diagnosis and management of hereditary colorectal cancer syndromes: Lynch syndrome as a model , 2009, Canadian Medical Association Journal.
[66] M. Ligtenberg,et al. Interpretation of Immunohistochemistry for Mismatch Repair Proteins is Only Reliable in a Specialized Setting , 2008, The American journal of surgical pathology.
[67] S. Tyekucheva,et al. The genome-wide determinants of human and chimpanzee microsatellite evolution. , 2007, Genome research.
[68] John D Potter,et al. Colon Cancer Family Registry: An International Resource for Studies of the Genetic Epidemiology of Colon Cancer , 2007, Cancer Epidemiology Biomarkers & Prevention.
[69] B. Iacopetta,et al. Heterogeneous staining for mismatch repair proteins during population-based prescreening for hereditary nonpolyposis colorectal cancer. , 2007, The Journal of molecular diagnostics : JMD.
[70] A. Duval,et al. Detection of microsatellite instability in endometrial cancer: advantages of a panel of five mononucleotide repeats over the National Cancer Institute panel of markers. , 2006, Carcinogenesis.
[71] E. Friedman,et al. Multipopulation analysis of polymorphisms in five mononucleotide repeats used to determine the microsatellite instability status of human tumors. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[72] R. Halberg,et al. Use of mononucleotide repeat markers for detection of microsatellite instability in mouse tumors , 2005, Molecular carcinogenesis.
[73] T. Kunkel,et al. DNA mismatch repair. , 2005, Annual review of biochemistry.
[74] A. Duval,et al. Quasimonomorphic Mononucleotide Repeats for High-Level Microsatellite Instability Analysis , 2004, Disease markers.
[75] Lawrence J. Burgart,et al. Development of a Fluorescent Multiplex Assay for Detection of MSI-High Tumors , 2004, Disease markers.
[76] Sudhir Srivastava,et al. Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. , 2004, Journal of the National Cancer Institute.
[77] L. Singh,et al. Genome-wide analysis of microsatellite repeats in humans: their abundance and density in specific genomic regions , 2003, Genome Biology.
[78] A. Duval,et al. Evaluation of tumor microsatellite instability using five quasimonomorphic mononucleotide repeats and pentaplex PCR. , 2002, Gastroenterology.
[79] Daniel J Sargent,et al. Immunohistochemistry versus microsatellite instability testing in phenotyping colorectal tumors. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[80] D. Shibata,et al. Stepwise deletions of polyA sequences in mismatch repair-deficient colorectal cancers. , 2001, The American journal of pathology.
[81] S Srivastava,et al. A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. , 1998, Cancer research.
[82] Darryl Shibata,et al. Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis , 1993, Nature.
[83] K. Kinzler,et al. Clues to the pathogenesis of familial colorectal cancer. , 1993, Science.
[84] S N Thibodeau,et al. Microsatellite instability in cancer of the proximal colon. , 1993, Science.
[85] G. Gutman,et al. Slipped-strand mispairing: a major mechanism for DNA sequence evolution. , 1987, Molecular biology and evolution.
[86] R. Eisenberg,et al. Differences in Microsatellite Instability Profiles between Endometrioid and Colorectal Cancers: A Potential Cause for False-Negative Results? , 2017, The Journal of molecular diagnostics : JMD.
[87] Suet Yi Leung,et al. Heritable somatic methylation and inactivation of MSH2 in families with Lynch syndrome due to deletion of the 3′ exons of TACSTD1 , 2009, Nature Genetics.
[88] Jeremy R. Jass,et al. HNPCC and Sporadic MSI-H Colorectal Cancer: A Review of the Morphological Similarities and Differences , 2004, Familial Cancer.